NATIONS FINANCIAL GROUP INC, /IA/ /ADV
Position in NVCT — Nuvectis Pharma, Inc.
CIK 1109767
CEDAR RAPIDS, IA
Position in NVCT
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$100,490
+$2,340 QoQ
Shares Held
13,000
0.0% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NATIONS FINANCIAL GROUP INC, /IA/ /ADV holds $3,466,943 across 9 Biotechnology names. NVCT ranks #3 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,490 | $2,004,964 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
15,177 | $980,889 | |
| 3 | NVCT |
Nuvectis Pharma, Inc.
This page
|
13,000 | $100,490 | |
| 4 | VNDA |
Vanda Pharmaceuticals Inc.
|
14,000 | $96,740 | |
| 5 | IMRX |
Immuneering Corp
|
17,000 | $89,590 | |
| 6 | PGEN |
Precigen, Inc.
|
15,500 | $59,985 | |
| 7 | ANIX |
Anixa Biosciences Inc
|
22,500 | $58,050 | |
| 8 | HYPD |
Hyperion Defi, Inc.
|
11,125 | $38,381 |
All Filings in NVCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100,490 | 13,000 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $98,150 | 13,000 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $78,260 | 13,000 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $97,110 | 13,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $131,895 | 13,500 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $73,035 | 13,500 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $62,900 | 10,000 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||